$2.06
0.020.98%
Last update: Nov 4, 9:28 AM
Fate Therapeutics Inc
FATENASDAQ
The average analyst price target for Fate Therapeutics is $5.89, 185.9% above the current price. Of 11 analysts, 6 rate it Buy, 4 Hold and 1 Sell. Targets range from $2 to $9. The latest change came on Aug 14, 2026, when Piper Sandler raised its price target on Fate Therapeutics from $6 to $8 and kept an Overweight rating.
Price Target Range — 11 Quarters
Analyst Consensus — 11 Analysts
Rating Trend — Last 9 Months
